New aspects of oestrogen/gestagen-induce
โ
H. G. Bohnet
๐
Article
๐
1986
๐
Springer
๐
English
โ 536 KB
Patients with Turner syndrome (n = 33) were subjected to a sequential oestrogen/gestagen replacement therapy (21 days 2 mg oestradiol valerate plus 0.5 mg norgestrel for 10 days) for 1-4 years. In individuals aged 12-17 years, growth velocities before treatment ranged between 2.9 and 1.9 cm/year and